Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
US Department of Justice
Argus Health
Farmers Insurance

Generated: December 18, 2017

DrugPatentWatch Database Preview


« Back to Dashboard

Which patents cover Latanoprost, and when can generic versions of Latanoprost launch?

Latanoprost is a drug marketed by Akorn, Amring Pharms, Apotex Inc, Bausch And Lomb, Dr Reddys Labs Ltd, Fdc Ltd, Mylan, and Sandoz Inc. and is included in eight NDAs.

The generic ingredient in LATANOPROST is latanoprost. There are nineteen drug master file entries for this compound. Seventeen suppliers are listed for this compound. There is one tentative approval for this compound. Additional details are available on the latanoprost profile page.
Drug patent expirations by year for LATANOPROST

Pharmacology for LATANOPROST

Drug ClassProstaglandin Analog

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
AkornLATANOPROSTlatanoprostSOLUTION/DROPS;OPHTHALMIC090887-001Jul 19, 2011ATRXNoNo► Subscribe► Subscribe► Subscribe
MylanLATANOPROSTlatanoprostSOLUTION/DROPS;OPHTHALMIC201786-001Mar 22, 2011ATRXNoNo► Subscribe► Subscribe► Subscribe
Bausch And LombLATANOPROSTlatanoprostSOLUTION/DROPS;OPHTHALMIC201006-001Mar 22, 2011ATRXNoNo► Subscribe► Subscribe► Subscribe
Sandoz IncLATANOPROSTlatanoprostSOLUTION/DROPS;OPHTHALMIC091449-001Mar 22, 2011ATRXNoNo► Subscribe► Subscribe► Subscribe
Amring PharmsLATANOPROSTlatanoprostSOLUTION/DROPS;OPHTHALMIC200925-001Mar 22, 2011ATRXNoNo► Subscribe► Subscribe► Subscribe
Apotex IncLATANOPROSTlatanoprostSOLUTION/DROPS;OPHTHALMIC077697-001Mar 22, 2011DISCNNoNo► Subscribe► Subscribe► Subscribe
Fdc LtdLATANOPROSTlatanoprostSOLUTION/DROPS;OPHTHALMIC202442-001Apr 22, 2016ATRXNoNo► Subscribe► Subscribe► Subscribe
Dr Reddys Labs LtdLATANOPROSTlatanoprostSOLUTION/DROPS;OPHTHALMIC202077-001Feb 11, 2013ATRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Queensland Health
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: